Grants per year
Personal profile
Certifications and Licenses
| Internal Medicine | |
| Infectious Disease |
Training Experience
| 1996 | Residency, Berkshire Medical Center |
| 2006 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MBBS, University of Ibadan, Nigeria
… → 1991
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 17 Similar Profiles
HIV
Medicine & Life Sciences
HIV-1
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Tenofovir
Medicine & Life Sciences
HIV Infections
Medicine & Life Sciences
Nigeria
Medicine & Life Sciences
Viral Load
Medicine & Life Sciences
Reverse Transcriptase Inhibitors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2004 2023
Clinical Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
Achenbach, C. J., D'Aquila, R. T., Hawkins, C. A., Hirschhorn, L. R., Maiga, M., Murphy, R. L., Taiwo, B. O. & Hou, L.
National Institute of Biomedical Imaging and Bioengineering
9/11/18 → 5/31/23
Project: Research project
Point-of-Care Systems
Acquired Immunodeficiency Syndrome
HIV
Biomedical Engineering
Mali
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian Adolescents
Hirschhorn, L. R., Janulis, P. F. & Taiwo, B. O.
National Institute of Child Health and Human Development
9/6/18 → 8/31/20
Project: Research project
HIV
Nigeria
Research
Capacity Building
Telemedicine
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria
Drane, D. L., Moskowitz, J. T., Ragin, A. B. & Taiwo, B. O.
John E. Fogarty International Center for Advanced Study in the Health Sciences
5/1/18 → 1/31/23
Project: Research project
Nigeria
HIV
Research
Education
Nervous System Diseases
Prot #GSK 204862: TANGO: A Phase III, Randomized, Multicenter, Parallel-Group, Non-Inferiority Study Evaluating the Efficacy, safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
PPD Investigator Services, LLC, GlaxoSmithKline LLC
4/4/18 → 4/4/21
Project: Research project
Prot #207966: A Phase IIIb, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every 8 Weeks or Every 4 Weeks i
PPD Investigator Services, LLC, GlaxoSmithKline LLC
2/7/18 → 2/7/21
Project: Research project
Research Output 2000 2019
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons
Riestenberg, R. A., Furman, A., Cowen, A., Pawlowksi, A., Schneider, D., Lewis, A. A., Kelly, S., Taiwo, B. O., Achenbach, C. J., Palella Jr, F. J., Stone, N. J., Lloyd-Jones, D. M. & Feinstein, M. J., Mar 1 2019, In : American heart journal. 209, p. 79-87 9 p.Research output: Contribution to journal › Article
Hydroxymethylglutaryl-CoA Reductase Inhibitors
HIV
Lipids
HIV Infections
Cardiovascular Diseases
1
Citation
(Scopus)
Frailty, neurocognitive impairment, or both in predicting poor health outcomes among adults living with human immunodeficiency virus
Erlandson, K. M., Perez, J., Abdo, M., Robertson, K., Ellis, R. J., Koletar, S. L., Kalayjian, R., Taiwo, B. O., Palella Jr, F. J. & Tassiopoulos, K., Jan 1 2019, In : Clinical Infectious Diseases. 68, 1, p. 131-138 8 p.Research output: Contribution to journal › Article
HIV
Health
Activities of Daily Living
CD4 Lymphocyte Count
Observational Studies
Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?
Kelly, S. G., Masters, M. C. & Taiwo, B. O., Jan 1 2019, In : Infectious disease clinics of North America.Research output: Contribution to journal › Review article
Integrase Inhibitors
Drug Therapy
Reverse Transcriptase Inhibitors
Lamivudine
Virus Diseases
No significant changes to residual viremia after switch to dolutegravir and lamivudine in a randomized trial
Li, J. Z., Sax, P. E., Marconi, V. C., Fajnzylber, J., Berzins, B., Nyaku, A. N., Fichtenbaum, C. J., Wilkin, T., Benson, C. A., Koletar, S. L., Lorenzo Redondo, R. & Taiwo, B. O., Mar 1 2019, In : Open Forum Infectious Diseases. 6, 3, 56.Research output: Contribution to journal › Article
Open Access
Lamivudine
Viremia
Drug Therapy
Random Allocation
Viral Load
1
Citation
(Scopus)
Physical Activity Is Associated with Lower Odds of Cognitive Impairment in Women but Not Men Living with Human Immunodeficiency Virus Infection
Chow, F. C., Makanjuola, A., Wu, K., Berzins, B., Kim, K-Y. A., Ogunniyi, A., Ellis, R. J., Robertson, K., Tassiopoulos, K. & Taiwo, B. O., Jan 7 2019, In : Journal of Infectious Diseases. 219, 2, p. 264-274 11 p.Research output: Contribution to journal › Article
Virus Diseases
HIV
Exercise
Logistic Models
Women's Health